Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

DBV Submits VIASKIN Peanut Patch for FDA Approval Following Phase 3 Success

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Potential Breakthrough for Celiac Disease: Teva Antibody Significantly Reduces Gluten-Induced Gut Damage

Rare Antibodies Could Lead to First Targeted Treatment for Alpha-Gal Syndrome

Another Potential Food Allergy Treatment is Snapped Up by Big Pharma

FDA Approves First Treatment for Eosinophilic Esophagitis (EoE), a Chronic Immune...

Prota Therapeutics Achieves 51% Peanut Allergy Remission Rate in Kids with...

FDA Accepts Dupixent® (dupilumab) for Priority Review in Patients Aged 12...

Peanut Allergy Immunotherapy Toothpaste Makes Strides Toward Phase 2 Trial

Stealth Mode Company Granted Patent for Sublingual Epinephrine Tablet

Sublingual Epinephrine for Anaphylaxis Receives Fast Track Designation from FDA

FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven...

CEO Expects Approval and Launch of Intranasal Emergency Epinephrine Spray by...

Aquestive’s Sublingual Epinephrine Achieves Therapeutic Blood Concentrations Following Administration

Positive Early Results with Fecal Microbiota Therapy for Peanut-Allergic Patients

Follow Us

Your School On Our Map

Put Your School on the Map